内部人交易记录
董事基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Discover the complete record of transactions filed by Brawley Otis W, 董事. Director active across 3 companies, notably INCYTE CORP. Cumulatively, 15 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €18k. Activity tracked since 27 September 2021. The latest transaction was disclosed on 19 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Brawley Otis W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
1,642 股Common StockSEC:0001213029-26-000005:0
2,158 股@ US$111.7515.9% 占其流量Common StockSEC:0001090872-26-000037:0
2,518 股0Common StockSEC:0001628280-25-031014:0
35,640 股@ US$0.56100.0% 占其流量Common StockSEC:0001415889-25-009604:0
1,819 股@ US$121.1817.3% 占其流量Common StockSEC:0001127602-25-009720:0
812 股@ US$121.187.7% 占其流量Common StockSEC:0001127602-25-009720:1
2,830 股0Common StockSEC:0000879169-24-000094:0
1,678 股@ US$147.4819.4% 占其流量Common StockSEC:0001127602-24-010681:0
750 股@ US$147.488.7% 占其流量Common StockSEC:0001127602-24-010681:1
2,505 股0Common StockSEC:0001209191-23-037793:0
1,658 股@ US$136.8218.3% 占其流量Common StockSEC:0000899243-23-009212:0
2,144 股0Common StockSEC:0001209191-22-037793:0
1,785 股@ US$136.8216.7% 占其流量Common StockSEC:0001127602-22-010046:0
404 股@ US$162.164.4% 占其流量Common StockSEC:0001127602-21-029665:0
1,255 股0Common StockSEC:0001209191-21-058108:0
About Brawley Otis W
BRAWLEY OTIS W is Administrateur at Agilent Technologies, INC., INCYTE CORP and Lyell Immunopharma, Inc. He has 15 filings in total, and across the recent sample of 15 filings, the cumulative buys are EUR 18448, the sells are EUR 0, with filings ranging from 2021-09-29 to 2026-06-10. The most frequent transaction nature is Attribution.